Beta-Catenin and SMAD3 Are Associated with Skeletal Muscle Aging in the Taurine Transpoeter Knockout Mouse

Takashi Ito1, Nao Yamamoto2, Shintaro Nakajima2

  • 1Department of Bioscience, Fukui Prefectural University, Fukui, Japan. tito@fpu.ac.jp.

Insights

Mice lacking the taurine transporter show accelerated skeletal muscle aging. This aging is linked to the activation of SMAD3 and beta-catenin signaling pathways, impacting cellular senescence biomarkers.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Gerontology

Background:

  • Taurine is crucial for cellular function.
  • Taurine transporter knockout (TauTKO) mice exhibit skeletal muscle abnormalities and accelerated aging.
  • The specific molecular pathways driving this aging process are not fully understood.

Purpose of the Study:

  • To investigate the signaling pathways responsible for accelerated skeletal muscle aging in TauTKO mice.
  • To identify upstream regulators of cellular senescence in taurine-depleted muscle.

Main Methods:

  • Bioinformatic analysis of transcriptome data from TauTKO mouse skeletal muscle.
  • DNA microarray for transcriptome profiling.
  • Western blot analysis to verify protein activation.

Main Results:

  • Transcriptome data predicted activation of SMAD3 and beta-catenin signaling.
  • These molecules are upstream regulators of CDKN2A (p16INK4A), a cellular senescence biomarker.
  • Western blot confirmed SMAD3 and beta-catenin activation in aged TauTKO muscle.

Conclusions:

  • Tissue taurine depletion accelerates skeletal muscle aging via SMAD3 and beta-catenin signaling.
  • This pathway leads to the induction of CDKN2A, a marker of cellular senescence.
  • Understanding this pathway offers insights into age-related muscle decline.